Intermediate monocytes are associated with the first major adverse cardiovascular event in patients with stable coronary artery disease
Mihaela Ioana Dregoesc, Adrian Bogdan Țigu, Siroon Bekkering, Charlotte D.C.C. van der Heijden, Laura Rodwell, Sorana D. Bolboacă, Leo A. B. Joosten, Mihai G. Netea, Niels P. Riksen, Adrian Corneliu Iancu
Topics & Concepts
MedicineMaceMyocardial infarctionInternal medicineCoronary artery diseaseCardiologyAcute coronary syndromeAdverse effectMonocytePercutaneous coronary interventionImmune cells in cancerCardiac Fibrosis and RemodelingAdipokines, Inflammation, and Metabolic Diseases